To include your compound in the COVID-19 Resource Center, submit it here.

Brandicourt joins Alnylam's board: plus Bayer, Jazz, Halozyme, Arena, Aurinia, Adverum, Neoleukin, Centogene, Epirium, Insilico, Nouscom, Eloxx, Nordic, Summit,

RNAi therapeutics company Alnylam Pharmaceuticals Inc. (NASDAQ:ALNY) said Olivier Brandicourt will join its board. Brandicourt, who retired as CEO of Sanofi (Euronext:SAN; NASDAQ:SNY) last year, also plans to join Blackstone Group as a senior adviser.

Bayer AG (Xetra:BAYN) said Norbert Winkeljohann will succeed Werner Wenning as chairman, effective April 28. Along with being on the pharma's board, Winkeljohann is chairman of PricewaterhouseCoopers Europe SE.

Sleep disorder

Read the full 640 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE